Motoki Ichikawa

759 total citations
32 papers, 623 citations indexed

About

Motoki Ichikawa is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Motoki Ichikawa has authored 32 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Motoki Ichikawa's work include Multiple Sclerosis Research Studies (8 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Motoki Ichikawa is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Motoki Ichikawa collaborates with scholars based in Japan, United States and Australia. Motoki Ichikawa's co-authors include Claude C.A. Bernard, Atsushi Komiyama, Yuji Inaba, John Slavin, Junliang Liu, Anthony Slavin, Christine Ewing, Makoto Itoh, Chang-Sung Koh and Atsushi Inoue and has published in prestigious journals such as The Journal of Immunology, Journal of Leukocyte Biology and Journal of the Neurological Sciences.

In The Last Decade

Motoki Ichikawa

32 papers receiving 616 citations

Peers

Motoki Ichikawa
Nobuo Koike United States
Matías Sáenz-Cuesta Spain
Patricia Fernández United States
Amberly Brown United States
Lauri R. Wyner United States
Masato Isome Japan
Clarissa Corinaldesi Italy
Edward Kim United States
Xiangnan Du China
Natalie V. Singer United States
Nobuo Koike United States
Motoki Ichikawa
Citations per year, relative to Motoki Ichikawa Motoki Ichikawa (= 1×) peers Nobuo Koike

Countries citing papers authored by Motoki Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Motoki Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoki Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoki Ichikawa more than expected).

Fields of papers citing papers by Motoki Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoki Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoki Ichikawa. The network helps show where Motoki Ichikawa may publish in the future.

Co-authorship network of co-authors of Motoki Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Motoki Ichikawa. A scholar is included among the top collaborators of Motoki Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motoki Ichikawa. Motoki Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Naoki, Motoki Ichikawa, Yuji Kamijo, et al.. (2016). PPARα-dependent cholesterol/testosterone disruption in Leydig cells mediates 2,4-dichlorophenoxyacetic acid-induced testicular toxicity in mice. Archives of Toxicology. 90(12). 3061–3071. 44 indexed citations
2.
Nishimura, Takafumi, Yuji Inaba, Yozo Nakazawa, et al.. (2015). Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis. Brain and Development. 37(8). 808–816. 10 indexed citations
3.
Motobayashi, Mitsuo, Yuji Inaba, Tetsuhiro Fukuyama, et al.. (2014). Successful treatment for West syndrome with severe combined immunodeficiency. Brain and Development. 37(1). 140–144. 8 indexed citations
4.
Hidaka, Yoshihiko, Yuji Inaba, Kazuyuki Matsuda, et al.. (2014). Cytokine production profiles in chronic relapsing–remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse. Journal of the Neurological Sciences. 340(1-2). 117–122. 29 indexed citations
5.
Inaba, Yuji, et al.. (2014). Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Neuroimmunology. 268(1-2). 25–34. 12 indexed citations
6.
Ehara, Takashi, et al.. (2013). Downregulation of water channel aquaporin-4 in rats with experimental autoimmune encephalomyeritis induced by myelin basic protein. Cellular Immunology. 281(1). 91–99. 5 indexed citations
7.
Ichikawa, Motoki, et al.. (2012). Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Neuroimmunology. 252(1-2). 66–74. 9 indexed citations
8.
Tsukahara, Teruomi, Takahito Wada, Yuji Inaba, et al.. (2011). Current State of “Infant Home Visiting Service for All Houses” in Nagano Prefecture. 59(3). 169–175. 1 indexed citations
9.
Hongo, Minoru, Hiroya Hidaka, Keisuke Nakanishi, et al.. (2010). Association Between Serum Uric Acid Levels and Cardiometabolic Risk Factors Among Japanese Junior High School Students. Circulation Journal. 74(8). 1570–1577. 33 indexed citations
10.
Imashuku, Shinsaku, Shuichi Ishida, Kenichi Koike, et al.. (2004). Cerebellar Ataxia in Pediatric Patients With Langerhans Cell Histiocytosis. Journal of Pediatric Hematology/Oncology. 26(11). 735–739. 15 indexed citations
11.
12.
13.
Inaba, Yuji, Motoki Ichikawa, Atsushi Inoue, et al.. (2001). Plasma thrombin–antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis. Journal of the Neurological Sciences. 185(2). 89–93. 19 indexed citations
14.
15.
Ichikawa, Motoki, Chang-Sung Koh, Yuji Inaba, et al.. (1999). IgG Subclass Switching Is Associated with the Severity of Experimental Autoimmune Encephalomyelitis Induced with Myelin Oligodendrocyte Glycoprotein Peptide in NOD Mice. Cellular Immunology. 191(2). 97–104. 32 indexed citations
16.
Inaba, Yuji, Motoki Ichikawa, Chang-Sung Koh, et al.. (1999). Suppression of Experimental Autoimmune Encephalomyelitis by Dermatan Sulfate. Cellular Immunology. 198(2). 96–102. 9 indexed citations
17.
Slavin, Anthony, Christine Ewing, Junliang Liu, et al.. (1998). Induction of a Multiple Sclerosis-Like Disease in Mice with an Immunodominant Epitope of Myelin Oligodendrocyte Glycoprotein. Autoimmunity. 28(2). 109–120. 118 indexed citations
18.
Inoue, Atsushi, Chang‐Sung Koh, Masashi Yamazaki, et al.. (1998). Suppressive Effect on Theiler’s Murine Encephalomyelitis Virus-Induced Demyelinating Disease by the Administration of Anti-IL-12 Antibody. The Journal of Immunology. 161(10). 5586–5593. 25 indexed citations
19.
Ichikawa, Motoki, et al.. (1996). Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. International Immunology. 8(11). 1667–1674. 30 indexed citations
20.
Ichikawa, Motoki, Yoshiro Amano, S. Matsuzawa, et al.. (1993). Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia Research. 17(5). 441–443. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuo Koike Breakdown of academic impact, for papers by Matías Sáenz-Cuesta Breakdown of academic impact, for papers by Patricia Fernández Breakdown of academic impact, for papers by Amberly Brown Breakdown of academic impact, for papers by Lauri R. Wyner Breakdown of academic impact, for papers by Masato Isome Breakdown of academic impact, for papers by Clarissa Corinaldesi Breakdown of academic impact, for papers by Edward Kim Breakdown of academic impact, for papers by Xiangnan Du Breakdown of academic impact, for papers by Natalie V. Singer
Rankless by CCL
2026